Seguir
julia chalaye
julia chalaye
praticien hospitalier, hopital henri mondor
Dirección de correo verificada de hmn.aphp.fr - Página principal
Título
Citado por
Citado por
Año
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma …
V Vilgrain, H Pereira, E Assenat, B Guiu, AD Ilonca, GP Pageaux, A Sibert, ...
The Lancet Oncology 18 (12), 1624-1636, 2017
7922017
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised …
E Garin, L Tselikas, B Guiu, J Chalaye, J Edeline, T de Baere, E Assenat, ...
The lancet Gastroenterology & hepatology 6 (1), 17-29, 2021
4032021
Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma
J Chalaye, CE Costentin, A Luciani, G Amaddeo, N Ganne-Carrié, ...
Journal of hepatology 69 (2), 336-344, 2018
662018
[18F]-NaF PET/CT imaging in cardiac amyloidosis
A Van Der Gucht, A Galat, J Rosso, A Guellich, J Garot, D Bodez, ...
Journal of nuclear cardiology 23, 846-849, 2016
532016
18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: a prospective observational study
C Lim, C Salloum, J Chalaye, E Lahat, CE Costentin, M Osseis, E Itti, ...
HPB 21 (6), 739-747, 2019
412019
Major impact of personalized dosimetry using 90Y loaded glass microspheres SIRT in HCC: Final overall survival analysis of a multicenter randomized phase II study (DOSISPHERE-01).
E Garin, L Tzelikas, B Guiu, J Chalaye, J Edeline, T De Baere, V Tacher, ...
Journal of Clinical Oncology 38 (4_suppl), 516-516, 2020
332020
Hepatocellular carcinomas with mutational activation of beta-catenin require choline and can be detected by positron emission tomography
A Gougelet, C Sartor, N Senni, J Calderaro, L Fartoux, M Lequoy, ...
Gastroenterology 157 (3), 807-822, 2019
292019
Neuropsychological correlates of brain perfusion SPECT in patients with macrophagic myofasciitis
A Van Der Gucht, M Aoun Sebaiti, E Itti, J Aouizerate, E Evangelista, ...
PLoS One 10 (6), e0128353, 2015
282015
Clinical impact of contrast-enhanced computed tomography combined with low-dose 18F-fluorodeoxyglucose positron emission tomography/computed …
J Chalaye, A Luciani, C Enache, P Beaussart, C Lhermite, E Evangelista, ...
Leukemia & Lymphoma 55 (12), 2887-2892, 2014
282014
Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria
M Ghosn, H Derbel, R Kharrat, N Oubaya, S Mulé, J Chalaye, H Regnault, ...
Diagnostic and Interventional Imaging 102 (1), 35-44, 2021
242021
Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and 18F-FDG PET/CT in patients on waiting-list for liver transplantation
S Boussouar, E Itti, SJ Lin, T Decaens, E Evangelista, M Chiaradia, ...
Cancer Imaging 16, 1-9, 2016
242016
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma …
S Mulé, J Chalaye, F Legou, A Tenenhaus, J Calderaro, ...
European Radiology 30, 5348-5357, 2020
202020
Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial)
H Pereira, M Bouattour, MD Burgio, E Assenat, J Grégory, JP Bronowicki, ...
European Journal of Cancer 154, 46-56, 2021
162021
Brain 18F-FDG PET metabolic abnormalities in patients with long-lasting macrophagic myofascitis
A Van Der Gucht, MA Sebaiti, E Guedj, J Aouizerate, S Yara, RK Gherardi, ...
Journal of Nuclear Medicine 58 (3), 492-498, 2017
162017
Chest PET/MRI in Solid Cancers: Comparing the Diagnostic Performance of a Free‐Breathing 3D‐T1‐GRE Stack‐of‐Stars Volume Interpolated Breath‐Hold Examination (StarVIBE …
M Vermersch, B Emsen, A Monnet, J Chalaye, A Galletto Pregliasco, ...
Journal of Magnetic Resonance Imaging 55 (6), 1683-1693, 2022
132022
Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes
B Emsen, G Villafane, JP David, E Evangelista, J Chalaye, L Lerman, ...
Medicine 99 (45), e23060, 2020
102020
Impact of the 18F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 Patients
M Vermersch, S Mulé, J Chalaye, A Galletto Pregliasco, B Emsen, ...
Journal of Clinical Medicine 10 (17), 4017, 2021
72021
Utility of Early Posttreatment PET/CT Evaluation Using FDG or 18F-FCH to Predict Response to 90Y Radioembolization in Patients With Hepatocellular Carcinoma
E Reizine, J Chalaye, S Mule, H Regnault, C Perrin, J Calderaro, ...
American Journal of Roentgenology 218 (2), 359-369, 2022
62022
Cost-utility analysis of transarterial radioembolization with Yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma
K Zarca, M Mimouni, H Pereira, G Chatellier, V Vilgrain, I Durand-Zaleski, ...
Clinical Therapeutics 43 (7), 1201-1212, 2021
62021
Brain 18F-FDG, 18F-Florbetaben PET/CT, 123I-FP-CIT SPECT and Cardiac 123I-MIBG Imaging for Diagnosis of a "Cerebral Type" of Lewy Body Disease
A Van Der Gucht, L Cleret de Langavant, O Bélissant, C Rabu, ...
Nuclear medicine and molecular imaging 50, 258-260, 2016
52016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20